Asensus surgical, inc. announces non-binding acquisition proposal and exclusivity arrangement with karl storz se & co. kg

Research triangle park, n.c., april 03, 2024 (globe newswire) -- asensus surgical , inc. (nyse american: asxc) (“asensus” or the “company”), a medical device company that is digitizing the interface between the surgeon and the patient, today announced that it has entered into a non-binding letter of intent (the “letter of intent”) with karl storz se & co. kg, an independent, family-owned global medical technology company (“karl storz”) to engage in diligence and negotiations regarding the terms of a potential transaction whereby karl storz may acquire asensus.
ASXC Ratings Summary
ASXC Quant Ranking